Puremed_Limited_31_Jul_2016_abbreviated_set_of_accounts.html

Puremed_Limited_31_Jul_2016_abbreviated_set_of_accounts.html


Private Limited CompanyCompany accountstrue1 August 2015FYtruetruefalsetruetruefalsexbrli:purexbrli:sharesiso4217:GBP073106622015-07-312016-07-31073106622016-07-31073106622015-07-3107310662uk-bus:Director12015-07-312016-07-31073106622015-08-0107310662uk-bus:OrdinaryShareClass12015-07-312016-07-3107310662uk-bus:OrdinaryShareClass12014-07-312015-07-3107310662uk-bus:OrdinaryShareClass12016-07-3107310662uk-bus:OrdinaryShareClass12015-07-31
Company registration number:
07310662
Puremed Limited
Abbreviated Financial Statements
for the year ended
31 July 2016
Puremed Limited
Abbreviated Balance Sheet
31 July 2016
20162015
Note££
Fixed assets    
Tangible assets #
133
 
133
 
Current assets    
Cash at bank and in hand
83
 
83
 
Creditors: amounts falling due within one year #
(1,863
)
(1,863
)
Net current liabilities
(1,780
)
(1,780
)
Total assets less current liabilities
(1,647
)
(1,647
)
Capital and reserves    
Called up share capital #
100
 
100
 
Profit and loss account
(1,747
)
(1,747
)
Shareholders deficit
(1,647
)
(1,647
)
For the year ending
31 July 2016
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
These abbreviated financial statements were approved by the board of directors and authorised for issue on
27 September 2016
, and are signed on behalf of the board by:
Mr Nick Dade
Director
Company registration number:
07310662
Puremed Limited
Notes to the Abbreviated Accounts
Year ended
31 July 2016

Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).

Tangible assets

Tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Fixtures fittings and equipment25% reducing balance basis

Financial instruments

Financial instruments are classified and accounted for according to the substance of contractual arrangements, as either financial assets, financial liabilities or equity instruments.

Operating leases

Leases are classified as operating leases where substantially all the benefits of ownerships remain with the lessor. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the lease term.

Tangible assets

£
Cost  
At
1 August 2015
178
 
At
31 July 2016
178
 
Depreciation  
At
1 August 2015
45
 
At
31 July 2016
45
 
Net book value  
At
31 July 2016
133
 
At 31 July 2015
133
 

Called up share capital

Allotted, called up and fully paid

20162015
No.£No.£
Ordinary
shares of £​
1.00
each
100
 
100
 
100
 
100